GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Virology

• Publication date

  1995-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/VIRO.1995.0052PMID 8553543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Translational Suppression in Retroviral GENE Expression

  2008cited by this paper
• An astrovirus frameshift signal induces ribosomal frameshifting in vitro

  2005cited by this paper
• Paramyxovirus mRNA editing leads to G deletions as well as insertions.

  1994cited by this paper
• Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein

  1993cited by this paper
• Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus.

  1993cited by this paper
• The envelope glycoprotein of Ebola virus contains an immunosuppressive‐like domain similar to oncogenic retroviruses

  1992cited by this paper
• Synthesis of leader RNA and editing of the P mRNA during transcription by purified measles virus

  1991cited by this paper
• The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein

  1991cited by this paper
• A Synthetic Peptide Homologous to Retroviral Transmembrane Envelope Proteins Depresses Protein Kinase C Mediated Lymphocyte Proliferation and Directly Inactivated Protein Kinase C: A Potential Mechanism for Immunosuppression

  1991cited by this paper
• The P gene of bovine parainfluenza virus 3 expresses all three reading frames from a single mRNA editing site.

  1991cited by this paper
• Glycosylation and oligomerization of the spike protein of marburg virus

  1991cited by this paper
• Sequence analysis of P gene of human parainfluenza type 2 virus: P and cysteine-rich proteins are translated by two mRNAs that differ by two nontemplated G residues.

  1990cited by this paper
• Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity

  1990cited by this paper
• A stuttering model for paramyxovirus P mRNA editing.

  1990cited by this paper
• Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system.

  1990cited by this paper
• Regulation of vaccinia virus transcription.

  1990cited by this paper
• Two nontemplated nucleotide additions are required to generate the P mRNA of parainfluenza virus type 2 since the RNA genome encodes protein V.

  1990cited by this paper
• Detection and characterization of mumps virus V protein.

  1990cited by this paper
• Sequence analysis of the phosphoprotein (P) genes of human parainfluenza type 4A and 4B viruses and RNA editing at transcript of the P genes: the number of G residues added is imprecise.

  1990cited by this paper
• RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts

  1990cited by this paper
• Measles virus editing provides an additional cysteine-rich protein.

  1989cited by this paper
• Physicochemical properties of Marburg virus: evidence for three distinct virus strains and their relationship to Ebola virus.

  1988cited by this paper
• HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems.

  1988cited by this paper
• Characterization of ribosomal frameshifting in HIV-1 gag-pol expression

  1988cited by this paper
• Signals for ribosomal frameshifting in the rous sarcoma virus gag-pol region

  1988cited by this paper
• Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5

  1988cited by this paper
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol

  1987cited by this paper
• Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins.

  1987cited by this paper
• Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

  1986cited by this paper
• Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

  1985cited by this paper
• Descriptive analysis of Ebola virus proteins.

  1985cited by this paper
• Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

  1985cited by this paper
• Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.

  1977cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Noncanonical P gene mRNA editing in Cedar virus generates a V-like protein that is required for efficient virion production

  2026cites this paper
• Antiviral defense against filovirus infections: targets and evasion mechanisms

  2025cites this paper
• Quantification of Filovirus Soluble Glycoprotein Using a Sandwich ELISA.

  2025cites this paper
• Comparison of the biological properties of bat-derived filovirus envelope glycoproteins

  2025cites this paper
• Reconceptualizing transcriptional slippage in plant RNA viruses

  2024cites this paper
• Prospects for the use of viral proteins for the construction of chimeric toxins

  2024cites this paper
• Novel proteolytic activation of Ebolavirus glycoprotein GP by TMPRSS2 and cathepsin L at an uncharted position can compensate for furin cleavage

  2024cites this paper
• Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity

  2024cites this paper
• RNA Editing as a General Trait of Ebolaviruses.

  2023cites this paper
• Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors

  2022cites this paper
• Development of an imaging system for visualization of Ebola virus glycoprotein throughout the viral lifecycle

  2022cites this paper
• Ebola virus delta peptide is an enterotoxin.

  2022cites this paper
• Enterotoxigenic Escherichia coli Heat-Stable Toxin and Ebola Virus Delta Peptide: Similarities and Differences

  2022cites this paper
• [Introduction of high containment laboratories in abroad].

  2022cites this paper
• Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

  2022cites this paper
• Development and Structural Analysis of Antibody Therapeutics for Filoviruses

  2022cites this paper
• Organization of minicircle cassettes and guide RNA genes in Trypanosoma brucei

  2022influential citation
• Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene

  2022cites this paper
• Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease

  2021cites this paper
• A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner

  2021cites this paper
• Integrated Proteomics and Transcriptomics Analyses Reveal the Transcriptional Slippage of a Bymovirus P3N-PIPO Gene Expressed from a PVX Vector in Nicotiana benthamiana

  2021cites this paper
• The only conserved microsatellite in coding regions of ebolavirus is the editing site.

  2021cites this paper
• The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway

  2021cites this paper
• Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein.

  2021cites this paper
• Genome structure and genetic diversity in the Ebola virus.

  2021cites this paper
• Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection

  2021influential citation
• Unconventional viral gene expression mechanisms as therapeutic targets

  2021cites this paper
• Structural Requirements in the Hemagglutinin Cleavage Site-Coding RNA Region for the Generation of Highly Pathogenic Avian Influenza Virus

  2021cites this paper
• Epitope specificity and protein signaling interactions driving

  2020cites this paper
• Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.

  2020cites this paper
• Characterization and analytical validation of a new antigenic rapid diagnostic test for Ebola virus disease detection

  2020cites this paper
• Ebola, the Negative Stranded RNA Virus

  2020cites this paper
• Virus Taxonomy The ICTV Report on Virus Classification and Taxon Nomenclature Secoviridae Chapter Secoviridae

  2020cites this paper
• Correction of frameshift mutations in the atpB gene by translational recoding in chloroplasts of Oenothera and tobacco

  2020influential citation
• Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection

  2020cites this paper
• Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion

  2019cites this paper
• 1 Characterization of the envelope glycoprotein of a novel filovirus , Lloviu virus 1 2

  2019influential citation
• A Focus on Ebola Virus Polymerase

  2019cites this paper
• Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection.

  2019cites this paper
• Charakterisierung der Rolle des endosomalen Recycling-Systems für den intrazellulären Transport des Marburg Virus Glykoproteins

  2019cites this paper
• Distinct genome replication and transcription strategies within the growing filovirus family.

  2019cites this paper
• Characterization of Ebola Virus VP30 Phosphorylation with a Phosphospecific Antibody

  2019cites this paper
• Ebola virus disease: An emerging and re-emerging viral threat.

  2019cites this paper
• Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects

  2019cites this paper
• Epidemiological Trends and Current Challenges in Ebola: Pathogen Biology, Drug Targets, and Therapeutic Strategies

  2019cites this paper
• The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development

  2019cites this paper
• Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription

  2019cites this paper
• Furin‐mediated protein processing in infectious diseases and cancer

  2019cites this paper
• Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors

  2019cites this paper
• Therapeutic strategies to target the Ebola virus life cycle

  2019cites this paper
• Development of a Human Antibody Cocktail that DeploysMultiple Functions toConfer Pan-Ebolavirus Protection Graphical

  2019cites this paper
• Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections

  2019cites this paper
• Filoviruses: Ecology, Molecular Biology, and Evolution.

  2018cites this paper
• Characterization of envelope glycoproteins of unisolated bat-derived viruses

  2018influential citation
• Proteolytic Processing of Filovirus Glycoproteins

  2018cites this paper
• Post-exposure treatments for Ebola and Marburg virus infections

  2018cites this paper
• Studies on virulence determinants of highly pathogenic avian influenza viruses

  2018cites this paper
• Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs

  2018cites this paper
• Host Factors Involved in Ebola Virus Replication.

  2018cites this paper
• Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors.

  2018cites this paper
• Ebolaviruses: New roles for old proteins

  2018cites this paper
• Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors

  2018cites this paper
• The highly efficient T7 RNA polymerase: A wonder macromolecule in biological realm.

  2018cites this paper
• Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.

  2018cites this paper
• Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled In Vitro Expression of Ebolavirus Glycoprotein

  2018cites this paper
• Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.

  2018cites this paper
• Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap

  2018cites this paper
• RNA Metabolism in Mitochondria

  2018cites this paper
• Editing of Mitochondrial RNAs in Physarum polycephalum

  2018cites this paper
• The structural basis for filovirus neutralization by monoclonal antibodies.

  2018cites this paper
• Ebola virus: an updated review on immunity and vaccine

  2018cites this paper
• Production, purification and immunogenicity of recombinant Ebola virus proteins - A comparison of Freund's adjuvant and adjuvant system 03.

  2017cites this paper
• Forty Years of Ebolavirus Molecular Biology: Understanding a Novel Disease Agent Through the Development and Application of New Technologies.

  2017cites this paper
• Virus-Vectored Ebola Vaccines

  2017cites this paper
• Human transmission of Ebola virus.

  2017cites this paper
• Ebola Virus Disease: Biology, Diagnosis, Treatment and Prevention of Epidemics

  2017cites this paper
• Reverse Genetics of Filoviruses.

  2017cites this paper
• Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG

  2017cites this paper
• Relationship between HLA and T cell responses to Ebola virus

  2017cites this paper
• Production and Purification of Filovirus Glycoproteins in Insect and Mammalian Cell Lines

  2017cites this paper
• Instructions for use Title Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein

  2017cites this paper
• Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution

  2017cites this paper
• Candidate Medical Countermeasures Targeting Ebola Virus Cell Entry

  2017cites this paper
• Mechanisms of Filovirus Entry.

  2017cites this paper
• Ebolavirus interferon antagonists-protein interaction perspectives to combat pathogenesis.

  2017cites this paper
• The study of highly pathogenic emerging zoonotic virus envelope proteins through pseudotyped virus generation

  2017cites this paper
• Genetic Predisposition To Acquire a Polybasic Cleavage Site for Highly Pathogenic Avian Influenza Virus Hemagglutinin

  2017cites this paper
• Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function

  2017cites this paper
• Ebola vaccine, therapeutics, and diagnostics.

  2016cites this paper
• Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection

  2016cites this paper
• Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses

  2016cites this paper
• Role of dendritic cells on Ebola virus immunity and dissemination

  2016cites this paper
• A small stem-loop structure of the Ebola virus trailer is essential for replication and interacts with heat-shock protein A8

  2016cites this paper
• Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.

  2016cites this paper
• Ebola Virus Infections

  2016cites this paper
• Evidence that a polyhexameric genome length is preferred, but not strictly required, for efficient mumps virus replication.

  2016cites this paper
• Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs

  2016cites this paper
• Molecular mechanisms of Ebola pathogenesis

  2016cites this paper
• Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection.

  2016cites this paper
• The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.

  2016cites this paper